These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1136 related items for PubMed ID: 18095227

  • 41. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
    Krueger WA, Unertl KE.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
    [Abstract] [Full Text] [Related]

  • 42. [Vancomycin resistant Enterococci (VRE)].
    Lesens O.
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. New drugs for Gram-positive uropathogens.
    Wagenlehner FM, Naber KG.
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S39-43. PubMed ID: 15364305
    [Abstract] [Full Text] [Related]

  • 45. Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.
    Młynarczyk G, Grzybowska W, Młynarczyk A, Tyski S, Kawecki D, Łuczak M, Chmura A, Rowiński W.
    Transplant Proc; 2007 Nov; 39(9):2883-5. PubMed ID: 18022008
    [Abstract] [Full Text] [Related]

  • 46. Enterococci: susceptibility patterns and therapeutic options.
    Nicoletti G, Stefani S.
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14 Suppl 1():S33-7. PubMed ID: 7729470
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature.
    Stevens MP, Edmond MB.
    Clin Infect Dis; 2005 Oct 15; 41(8):1134-42. PubMed ID: 16163631
    [Abstract] [Full Text] [Related]

  • 49. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
    Jankowski A, Stefanik W.
    Wiad Lek; 2006 Oct 15; 59(9-10):727-31. PubMed ID: 17338140
    [Abstract] [Full Text] [Related]

  • 50. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM.
    Clin Infect Dis; 2003 Feb 15; 36(4):473-81. PubMed ID: 12567306
    [Abstract] [Full Text] [Related]

  • 51. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Low DE, Keller N, Barth A, Jones RN.
    Clin Infect Dis; 2001 May 15; 32 Suppl 2():S133-45. PubMed ID: 11320453
    [Abstract] [Full Text] [Related]

  • 52. [Enterococcal endocarditis: a multicenter study of 76 cases].
    Martínez-Marcos FJ, Lomas-Cabezas JM, Hidalgo-Tenorio C, de la Torre-Lima J, Plata-Ciézar A, Reguera-Iglesias JM, Ruiz-Morales J, Márquez-Solero M, Gálvez-Acebal J, de Alarcón-González A, Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas.
    Enferm Infecc Microbiol Clin; 2009 Dec 15; 27(10):571-9. PubMed ID: 19477041
    [Abstract] [Full Text] [Related]

  • 53. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
    Chou CH, Lee NY, Lee HC, Chang CM, Lee CC, Ko WC.
    J Microbiol Immunol Infect; 2012 Jun 15; 45(3):221-7. PubMed ID: 22578639
    [Abstract] [Full Text] [Related]

  • 54. Multidrug-resistant enterococci: a threat to the surgical patient.
    Low DE, Willey BM, McGeer AJ.
    Am J Surg; 1995 May 15; 169(5A Suppl):8S-12S. PubMed ID: 7755167
    [Abstract] [Full Text] [Related]

  • 55. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI, Mejías A, Katz KS, Revell P, McCracken GH, Sánchez PJ.
    Pediatr Infect Dis J; 2007 Dec 15; 26(12):1128-32. PubMed ID: 18043450
    [Abstract] [Full Text] [Related]

  • 56. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M, Wixson RL, Pertel PE.
    Clin Infect Dis; 2002 May 15; 34(10):1412-4. PubMed ID: 11981739
    [Abstract] [Full Text] [Related]

  • 57. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA, Wysome J, West AP, Heritage J, Wilcox MH.
    J Antimicrob Chemother; 2006 Apr 15; 57(4):767-70. PubMed ID: 16464896
    [Abstract] [Full Text] [Related]

  • 58. Emerging resistance in Enterococcus spp.
    Heath CH, Blackmore TK, Gordon DL.
    Med J Aust; 1996 Jan 15; 164(2):116-20. PubMed ID: 8569563
    [Abstract] [Full Text] [Related]

  • 59. New antimicrobial agents for the treatment of Gram-positive bacterial infections.
    Aksoy DY, Unal S.
    Clin Microbiol Infect; 2008 May 15; 14(5):411-20. PubMed ID: 18261129
    [Abstract] [Full Text] [Related]

  • 60. The emergence of enterococci as a cause of nosocomial infection.
    Hunt CP.
    Br J Biomed Sci; 1998 Jun 15; 55(2):149-56. PubMed ID: 10198473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.